右美沙芬作为去甲丙咪嗪羟化多态性的安全探针。 - Suppr

Suppr

超能文献

Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.

作者信息

Küpfer A, Schmid B, Preisig R, Pfaff G

出版信息

Lancet. 1984 Sep 1;2(8401):517-8. doi: 10.1016/s0140-6736(84)92591-1.

DOI:10.1016/s0140-6736(84)92591-1

PMID:6147572

Abstract

摘要

相似文献

Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.

Lancet. 1984 Sep 1;2(8401):517-8. doi: 10.1016/s0140-6736(84)92591-1.

Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism.

Lancet. 1984 Dec 15;2(8416):1393. doi: 10.1016/s0140-6736(84)92081-6.

Pharmacogenetics of dextromethorphan O-demethylation in man.

Xenobiotica. 1986 May;16(5):421-33. doi: 10.3109/00498258609050249.

Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.

Clin Pharmacol Ther. 1989 Mar;45(3):328-33. doi: 10.1038/clpt.1989.36.

In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.

Biochem Pharmacol. 1988 Aug 15;37(16):3155-60. doi: 10.1016/0006-2952(88)90314-0.

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.

Clin Pharmacol Ther. 1989 May;45(5):568-73. doi: 10.1038/clpt.1989.74.

Polymorphism of debrisoquine hydroxylation among Finns and Lapps.

Br J Clin Pharmacol. 1988 Nov;26(5):601-3. doi: 10.1111/j.1365-2125.1988.tb05301.x.

Debrisoquine hydroxylation phenotyping: do we expect too much?

Lancet. 1990 Sep 15;336(8716):694. doi: 10.1016/0140-6736(90)92193-l.

Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

Br J Clin Pharmacol. 1989 Feb;27(2):223-7. doi: 10.1111/j.1365-2125.1989.tb05354.x.

Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians.

Pharmacol Toxicol. 1993 Feb;72(2):113-5. doi: 10.1111/j.1600-0773.1993.tb00300.x.

引用本文的文献

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Schizophr Bull. 2012 Sep;38(5):942-9. doi: 10.1093/schbul/sbs075. Epub 2012 Aug 16.

Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.

Br J Clin Pharmacol. 1993 Dec;36(6):531-8. doi: 10.1111/j.1365-2125.1993.tb00411.x.

Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.

Eur J Drug Metab Pharmacokinet. 1998 Jan-Mar;23(1):1-5. doi: 10.1007/BF03189819.

Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.

Eur J Drug Metab Pharmacokinet. 1996 Oct-Dec;21(4):301-7. doi: 10.1007/BF03189731.

Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.

J Psychiatry Neurosci. 1994 Jan;19(1):30-44.

Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probes.

Cancer Chemother Pharmacol. 1995;36(2):125-8. doi: 10.1007/BF00689196.

Polymorphism of dextromethorphan oxidation in a French population.

Br J Clin Pharmacol. 1987 Nov;24(5):676-9. doi: 10.1111/j.1365-2125.1987.tb03230.x.

Phenotyping polymorphic drug metabolism in the French Caucasian population.

Eur J Clin Pharmacol. 1988;35(2):167-71. doi: 10.1007/BF00609247.

Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003.

Effect of quinidine on the dextromethorphan O-demethylase activity of microsomal fractions from human liver.

Br J Clin Pharmacol. 1989 Jul;28(1):29-36. doi: 10.1111/j.1365-2125.1989.tb03502.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验